FWM
SIOX

Focused Wealth Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Focused Wealth Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500
Closed -$1K – 1140
2021
Q3 		$1K Hold
500
– – ﹤0.01% 971
2021
Q2 		$1K Buy
+500
New +$1.24K ﹤0.01% 911

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Focused Wealth Management's SIOX Position: Q4 2021 in Review

Focused Wealth Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2021, closing a stake of 500 shares — an estimated $1K sold.

Focused Wealth Management first reported a position in SIOX in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 48 funds tracked by Wall St. Rank hold SIOX as of Q4 2021.

  • Focused Wealth Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Focused Wealth Management sold 500 Sio Gene Therapies Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • Focused Wealth Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Focused Wealth Management's Sio Gene Therapies Inc. Common Stock position peaked at $1K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2021.

Based on Focused Wealth Management's 13F filing for Q4 2021, filed 31 Jan 2022.